Lupin continues to be on the lookout for meaningful targets, be it brands or technology companies, in inhalation, complex injectables and skin... ...http://www.livemint.com/Companies/zAqHfAAp7lZcFney838mRN/Lupin-scouts-for-acquisitions-in-US.html
With the mood remaining fairly positive, the market, despite paring some gains once again, looks set to end with moderate gains today. Optimism... ...http://www.sify.com/finance/sensex-up-105-pts-set-to-end-on-firm-note-news-sensex-okvprijahaifa.html
The company and its US partner, Breckenridge, have a license to market generic versions of Nuvigil (armodafinil) with 180 days exclusivity period... ...http://www.business-standard.com/content/b2b-pharma/natco-receives-usfda-tentative-approval-for-armodafinil-tablets-114102100766_1.html
Natco Pharma is currently trading at Rs. 1329.00, up by 67.40 points or 5.34% from its previous closing of Rs. 1261.60 on the BSE. The scrip... ...http://acml.accordfintech.com/News/NewsDetails.aspx?sec=4&subsec=38&Newsid=339641&id=1
Natco Pharma, one of the few Indian companies to venture into new drug discovery research, announced that its marketing partner in the USA,... ...http://www.myiris.com/newsCentre/storyShow.php?fileR=20141021123527715&dir=2014/10/21&secID=livenews&code1=&code=
Miocon is pleased to introduce...